Wavozen

787 Ready for breakout instead of breakout failure

Long
Wavozen Updated   
NSE:SUNPHARMA   SUN PHARMACEUTICAL
SL compulsory
Trade active:
2% gain for intraday.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.